The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Hypoxia signalling in cancer and approaches to enforce tumour regression
Abstract
Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The affinity of PHDs and FIH-1 for oxygen differs and, since FIH-1 has a higher affinity (lower K m ) for oxygen, PHDs are thought to be more rapidly inhibited in low oxygen conditions (Pouyssegur et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Pouyssegur et al., 2006
In the citing paper
“this is recognized to have profound effects on the tumor metabolism (92)(93)(94)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
In the citing paper
“O 2 tension in the center of solid tumors may be so low that cells essentially become anoxic”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [93]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Cited by
Sorted by citations
Items 701–800 of 1,002
Martinive, P., Defresne, F., Quaghebeur, E., Daneau, G., Crokart, N., Grégoire, V., Gallez, B., Dessy, C., & Féron, O. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06798.x · Cited by 44
Tang, K. L., Toyozumi, T., Murakami, K., Sakata, H., Kano, M., Endo, S., Matsumoto, Y., Suito, H., Takahashi, M., Sekino, N., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01825-3 · Cited by 43
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Hypoxic conditions differentially regulate TAZ and YAP in cancer cells
Yan, L., Cai, Q., & Xu, Y. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.024 · Cited by 43
Hao, H., Ma, Q., He, F., & Yao, P. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01359j · Cited by 43
Hulı́ková, A., Aveyard, N., Harris, A. L., Vaughan‐Jones, R. D., & Swietach, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547844 · Cited by 43
Zheng, G., Peng, C., Jia, X., Gu, Y., Zhang, Z., Deng, Y., Wang, C., Li, N., Yin, J., Liu, X., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0357-6 · Cited by 43
Targeting Angiogenesis in Esophagogastric Adenocarcinoma
Okines, A. F. C., Reynolds, A. R., & Cunningham, D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0387 · Cited by 43
Novel approaches for designing drugs that interfere with pH regulation
Berrino, E., & Supuran, C. T. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1567488 · Cited by 43
Hu, Y., Zhang, T., Chen, J., Cheng, W., Chen, J., Zheng, Z., Lin, J., Zhu, G., Zhang, Y., Bai, X., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.014 · Cited by 43
Jiang, Z., Xiong, H., Yang, S., Lü, Y., Deng, Y., Yao, J., & Yao, J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000075 · Cited by 42
Shihab, I., Khalil, B. A., Elemam, N. M., Hachim, I. Y., Hachim, M. Y., Hamoudi, R., & Maghazachi, A. A. (2020) · Cancers · doi:10.3390/cancers12082226 · Cited by 42
Design strategies and applications of smart optical probes in the second near-infrared window
Chang, B., Chen, J., Bao, J., Dong, K., Chen, S., & Cheng, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114637 · Cited by 46
Favaro, E., Nardo, G., Persano, L., Masiero, M., Moserle, L., Zamarchi, R., Rossi, E. M. C., Esposito, G., Plebani, M., Sattler, U. G. A., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071183 · Cited by 42
Biscetti, F., Straface, G., Arena, V., Stigliano, E., Pecorini, G., Rizzo, P., Angelis, G. D., Iuliano, L., Ghirlanda, G., & Flex, A. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-49 · Cited by 43
Biosensors to Monitor Cell Activity in 3D Hydrogel-Based Tissue Models
Fedi, A., Vitale, C., Giannoni, P., Caluori, G., & Marrella, A. (2022) · Sensors · doi:10.3390/s22041517 · Cited by 46
The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas
Vemulapalli, S., Mita, A. C., Alvarado, Y., Sankhala, K. K., & Mita, M. M. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0179-4 · Cited by 42
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010)
Ban, H. S., Uto, Y., & Nakamura, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.547477 · Cited by 42
Mimura, I., Tanaka, T., Wada, Y., Kodama, T., & Nangaku, M. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r19fm · Cited by 42
Possik, P. A., Müller, J., Gerlach, C., Kenski, J. C. N., Huang, X., Shahrabi, A., Krijgsman, O., Song, J., Smit, M. A., Gerritsen, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.024 · Cited by 43
Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α Signaling
Paatero, I., Jokilammi, A., Heikkinen, P. T., Iljin, K., Kallioniemi, O., Jones, F. E., Jaakkola, P., & Elenius, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299537 · Cited by 46
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases
Niklander, S. E., Bordagaray, M. J., Fernández, A., V, & Hernández, M. (2021) · Biomolecules · doi:10.3390/biom11010085 · Cited by 47
Oncostatic effects of fluoxetine in experimental colon cancer models
Kannen, V., Garcia, S. B., Silva, W. A., Gasser, M., Moench, R., Alho, E. J. L., Heinsen, H., Scholz, C. J., Friedrich, M., Heinze, K. G., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.008 · Cited by 42
Ji, C., Li, H., Zhang, L., Wang, P., Lv, Y., Sun, Z., Tan, J., Yuan, Q., & Tan, W. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200237 · Cited by 42
Hypoxia induced overexpression of PrPC in gastric cancer cell lines
Liang, J., Bai, F., Luo, G., Wang, J., Liu, J., Ge, F., Pan, Y., Yao, L., Du, R., Li, X., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.4001 · Cited by 41
HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia
Wrann, S., Kaufmann, M. R., Wirthner, R., Stiehl, D. P., & Wenger, R. H. (2012) · Biological Chemistry · doi:10.1515/hsz-2012-0311 · Cited by 41
Kim, D. H., Sung, B., Kim, J.-A., Kang, Y. J., Hwang, S. Y., Hwang, N. L., Suh, H., Choi, Y. H., Im, E., Chung, H. Y., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4058 · Cited by 42
Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., & Parola, M. (2014) · PubMed · doi:10.14670/hh-29.33 · Cited by 41
Jeon, Y.-K., Park, S.-G., Choi, I.-W., Lee, S.-W., Lee, S. M., & Choi, I. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.098 · Cited by 41
Oct‐3/4 promotes migration and invasion of glioblastoma cells
Kobayashi, K., Takahashi, H., Inoue, A., Harada, H., Toshimori, S., Kobayashi, Y., Katsuhiro, G. O. T. O., Sugimoto, K., Yano, H., Ohnishi, T., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23374 · Cited by 43
Gao, F., Chattopadhyay, A., Navab, M., Grijalva, V. R., Su, F., Fogelman, A. M., Reddy, S. T., & Farias‐Eisner, R. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191544 · Cited by 41
Tan, Z., Wang, C., Li, X., & Guan, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00210 · Cited by 42
Inhibition of miR-135b by SP-1 promotes hypoxia-induced vascular endothelial cell injury via HIF-1α
Yang, S., Yin, J. Y., & Hou, X. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.001 · Cited by 41
Zhu, P., Wang, M., Chen, Z.-L., & Yang, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761107 · Cited by 45
Resveratrol Reduces the Hypoxia-Induced Resistance to Doxorubicin in Breast Cancer Cells
Mitani, T., Ito, Y., Harada, N., Nakano, Y., Inui, H., Ashida, H., & Yamaji, R. (2014) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.60.122 · Cited by 41
Magagnin, M. G., Koritzinsky, M., & Wouters, B. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.07.002 · Cited by 41
Zhou, W., Dosey, T. L., Biechele, T. L., Moon, R. T., Horwitz, M. S., & Ruohola‐Baker, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027460 · Cited by 41
Role of Carcinoma-Associated Fibroblasts and Hypoxia in Tumor Progression
Giaccia, A. J., & Schipani, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_73 · Cited by 43
Chang, L., Wu, P., Senthilkumar, R., Tian, X., Liu, H., Shen, X., Tao, Z., & Huang, P. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2000-8 · Cited by 39
Stewart, G. D., Lowrie, A. G., Riddick, A. C. P., Fearon, K. C. H., Habib, F. K., & Ross, J. A. (2007) · The Prostate · doi:10.1002/pros.20618 · Cited by 41
Vigneswaran, N., Wu, J. G., Song, A., Annapragada, A., & Zacharias, W. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.11.011 · Cited by 40
Kim, D.-H., Gutiérrez‐Aguilar, R., Kim, H.-J., Woods, S. C., & Seeley, R. J. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.141 · Cited by 42
Naruse, T., Kawasaki, G., Yanamoto, S., Mizuno, A., & Umeda, M. (2011) · PubMed · Cited by 40
Sun, H., Zhang, M., Cheng, K., Li, P., Han, S., Li, R., Su, M., Zeng, W., Liu, J., Guo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12803 · Cited by 40
Glucose Metabolism Reprogrammed by Overexpression of IKKϵ Promotes Pancreatic Tumor Growth
Zubair, H., Azim, S., Srivastava, S. K., Ahmad, A., Bhardwaj, A., Khan, M. A., Patel, G. K., Arora, S., Carter, J. E., Singh, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1666 · Cited by 40
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
Yang, X., Liang, X., Zheng, M. H., & Tang, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00505 · Cited by 42
Vučetić, M., Daher, B., Cassim, S., Meira, W., & Pouysségur, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02994-w · Cited by 40
Self-citationCaspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
Lou, J., Zhou, Y., Feng, Z., Ma, M., Yao, Y., Wang, Y., Deng, Y., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616952 · Cited by 39
Shapiro, G. I., McCallum, S. W., Adams, L. M., Sherman, L. J., Weller, S., Swann, S., Keer, H. N., Miles, D., Müller, T. R., Rabe, D. C., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0287-6 · Cited by 40
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Duan, Q., Zhang, S., Wang, Y., Lu, D., Sun, Y., & Wu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1069555 · Cited by 40
Mikuriya, Y., Tashiro, H., Kuroda, S., Nambu, J., Kobayashi, T., Amano, H., Tanaka, Y., & Ohdan, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29096 · Cited by 38
Wiesener, M. S., Münchenhagen, P., Gläser, M., Sobottka, B., Knaup, K. X., Jozefowski, K., Jürgensen, J. S., Roigas, J., Warnecke, C., Gröne, H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22961 · Cited by 40
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model
Trédan, O., Lacroix‐Triki, M., Guiu, S., Mouret‐Reynier, M., Barrière, J., Bidard, F., Braccini, A.-L., Mir, O., Villanueva, C., & Barthélémy, P. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0334-9 · Cited by 42
Wiese, M., Gerlach, R. G., Popp, I., Matuszak, J., Mahapatro, M., Castiglione, K., Chakravortty, D., Willam, C., Hensel, M., Bogdan, C., et al. (2012) · Infection and Immunity · doi:10.1128/iai.05972-11 · Cited by 39
Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis
Xu, Y., Xia, X., & Pan, H. (2012) · Oncology Letters · doi:10.3892/ol.2012.1015 · Cited by 39
Eskandani, M., Vandghanooni, S., Barar, J., Nazemiyeh, H., & Omidi, Y. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.113 · Cited by 40
Lee, D.-H., Oh, S. C., Giles, A. J., Jung, J., Gilbert, M. R., & Park, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16714 · Cited by 40
Prasad, C. P., Södergren, K., & Andersson, T. (2017) · Oncotarget · doi:10.18632/oncotarget.17277 · Cited by 39
Stimuli-Regulated Smart Polymeric Systems for Gene Therapy
Mathew, A. P., Cho, K., Uthaman, S., Cho, C., & Park, I. (2017) · Polymers · doi:10.3390/polym9040152 · Cited by 39
Cardiovascular adaptation to hypoxia and the role of peripheral resistance
Cowburn, A., Macías, D., Summers, C., Chilvers, E., & Johnson, R. (2017) · eLife · doi:10.7554/elife.28755 · Cited by 33
Cheng, S.-Y., Chen, N., Lin, P., Su, J., Chen, B., Kuo, H., Sung, C., Sung, P., Wen, Z., & Chen, W.-F. (2019) · Cancers · doi:10.3390/cancers11020220 · Cited by 39
Pan, W., Wang, H., Zhang, X., Xu, P., Wang, G., Li, Y., Huang, K., Zhang, Y., Zhao, H., Du, R., et al. (2020) · Hepatology · doi:10.1002/hep.31221 · Cited by 40
Huang, T., Lin, B. M., Stampfer, M. J., Schernhammer, E. S., Saxena, R., Tworoger, S. S., & Redline, S. S. (2020) · SLEEP · doi:10.1093/sleep/zsaa198 · Cited by 41
Radiation-induced modifications of the tumor microenvironment promote metastasis
Rüegg, C., Monnier, Y., Kuonen, F., & Imaizumi, N. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1372 · Cited by 39
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
Li, M., Wei, J., Xue, C., Zhou, X., Chen, S., Zheng, L., Duan, Y., Deng, H., Xiong, W., Tang, F., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122110 · Cited by 39
Pelletier, J., Dayan, F., Durivault, J., Ilc, K., Pécou, E., Pouysségur, J., & Mazure, N. M. (2011) · Oncogene · doi:10.1038/onc.2011.471 · Cited by 41
Self-citationGothai, S., Muniandy, K., Gnanaraj, C., Ibrahim, I. A. A., Shahzad, N., Alghamdi, S., Ayoub, N., Veeraraghavan, V. P., Kumar, S. S., Norhaizan, M. E., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.112 · Cited by 38
Exploiting Nanomaterial‐Mediated Autophagy for Cancer Therapy
Wei, W., Rosenkrans, Z. T., Luo, Q., Lan, X., & Cai, W. (2018) · Small Methods · doi:10.1002/smtd.201800365 · Cited by 41
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
Gillson, J., El-Aziz, Y. S. A., Leck, L. Y. W., Jansson, P. J., Pavlakis, N., Samra, J. S., Mittal, A., & Sahni, S. (2022) · Cancers · doi:10.3390/cancers14143528 · Cited by 38
Prolidase-dependent regulation of TGF c and TGF β receptor expressions in human skin fibroblasts
Surażyński, A., Miltyk, W., Prokop, I., & Palka, J. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.034 · Cited by 38
Abreu, P. L., Ferreira, L. M. R., Alpoim, M. C., & Urbano, A. M. (2014) · BioMetals · doi:10.1007/s10534-014-9726-7 · Cited by 39
Ravizza, R., Molteni, R., Gariboldi, M. B., Marras, E., Perletti, G., & Monti, E. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.021 · Cited by 38
Melgar‐Lesmes, P., Tugues, S., Ros, J., Fernández‐Varo, G., Morales‐Ruiz, M., Rodés, J., & Jiménez, W. (2008) · Gut · doi:10.1136/gut.2008.155028 · Cited by 38
FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α
Shi, L., He, C., Li, Z., Wang, Z., & Zhang, Q. (2017) · Neoplasma · doi:10.4149/neo_2017_407 · Cited by 39
Shin, D. H., Li, S. H., Yang, S., Lee, B. L., Lee, M. K., & Park, J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07069.x · Cited by 38
Targeting vasculature in urologic tumors: Mechanistic and therapeutic significance
Sakamoto, S., Ryan, A. J., & Kyprianou, N. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21442 · Cited by 40
Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition
Hallis, S. P., Kim, S. K., Lee, J., & Kwak, M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102632 · Cited by 38
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
Robles-Oteíza, C., Hastings, K., Choi, J., Sirois, I., Ravi, A., Expósito, F., de Miguel, F. J., Knight, J., López‐Giráldez, F., Choi, H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231106 · Cited by 39
Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line
Mikami, Y., Hisatsune, A., Tashiro, T., Isohama, Y., & Katsuki, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.002 · Cited by 37
Linares, P. M., Chaparro, M., & Gisbert, J. P. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.06.013 · Cited by 38
Wang, R., He, W., Li, Z., Chang, W., Yue, X., & Huang, T. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1836 · Cited by 37
Huang, Y., Liu, B., Shen, Q., Zhu, X., Hao, Y., Chang, Z., Xu, F., Qu, P., & Xu, M. (2016) · Talanta · doi:10.1016/j.talanta.2016.07.028 · Cited by 37
Fraga, A. M., Ribeiro, R. J. T., Coelho, A., Vizcaino, J. R., Coutinho, H., Lopes, J. M., Príncipe, P., Lobato, C., Lopes, C., & Medeiros, R. (2017) · BMC Urology · doi:10.1186/s12894-017-0201-y · Cited by 37
Saavedra-García, P., Román-Trufero, M., Al-Sadah, H. A., Blighe, K., López-Jiménez, E. A., Christoforou, M., Penfold, L., Capece, D., Xiong, X., Miao, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018229118 · Cited by 39
Hypoxia and low‐nutrition double stress induces aggressiveness in a murine model of melanoma
Osawa, T., Muramatsu, M., Watanabe, M., & Shibuya, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01105.x · Cited by 37
Qi, L., Zhu, F., Li, S., Si, L., Hu, L., & Tian, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106032 · Cited by 37
Paeng, S. H., Jung, W., Park, W. S., Lee, D.-S., Kim, G., Choi, Y. H., Seo, S., Jang, W. H., Choi, J. S., Lee, Y., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2116 · Cited by 40
Cho, E. A., Song, H. K., Lee, S., Chung, B. H., Lim, H. M., & Lee, M. K. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24423 · Cited by 37
Regulated Function of the Prolyl-4-Hydroxylase Domain (PHD) Oxygen Sensor Proteins
Nytko, K. J., Spielmann, P., Camenisch, G., Wenger, R. H., & Stiehl, D. P. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1683 · Cited by 37
Ahuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 43
Schelter, F., Halbgewachs, B., Baeumler, P. I., Neu, C., Görlach, A., Schrötzlmair, F., & Krüger, A. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9360-x · Cited by 36
Tanimoto, K., Tsuchihara, K., Kanai, A., Arauchi, T., Esumi, H., Suzuki, Y., & Sugano, S. (2010) · The HUGO Journal · doi:10.1007/s11568-011-9150-9 · Cited by 36
Segler, A., & Tsimberidou, A. M. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1874-2 · Cited by 36
Mamalis, A. A., & Cochran, D. L. (2011) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2011.05.001 · Cited by 36
HIF-1α promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model
Zhu, J., Huang, Z., Zhang, M., Wang, W., Liang, H., Zeng, J., Wu, K., Wang, X., Hsieh, J., Guo, P., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7764 · Cited by 38
The role of tumour microenvironment: a new vision for cholangiocarcinoma
Chen, Z., Guo, P., Xie, X., Yu, H., Wang, Y., & Chen, G. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13953 · Cited by 36
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
Ikeda, S., & Tagawa, H. (2021) · Cancer Science · doi:10.1111/cas.15087 · Cited by 36
Avnet, S., Lemma, S., Cortini, M., Pompo, G. D., Perut, F., Lipreri, M. V., Roncuzzi, L., Columbaro, M., Errani, C., Longhi, A., et al. (2021) · Cancers · doi:10.3390/cancers13225855 · Cited by 37
Metadata
- Authors
- Pouysségur, J., Dayan, F., & Mazure, N. M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Pouysségur, Jacques
- Venue
- Nature
- Published
- 2006-05-24
- Volume
- 441
- Issue
- 7092
- Pages
- 437-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2082483448
- Semantic Scholar
- 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
- Cited by
- 1,676
- References
- 104
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
- MeSH terms
- Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review